Dante’s oncologist, Dr. Bernie Eigl, deputy head, department of clinical research at BC Cancer, referred him to a BC Cancer ...

Prostate cancer is a significant health issue in India, with 37,000 new cases and 18,000 deaths annually. AI is ...

It’s been a year since King Charles was diagnosed with cancer on February 5, 2024. Buckingham Palace confirmed the monarch, ...

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

Northwell Staten Island University Hospital has announced the addition of the Focal One High-Intensity Focused Ultrasound ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

but their optimal use—such as which drug or drug combinations should be used first to achieve the best outcomes from prostate cancer treatment—is still being worked out. Nevertheless ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.